21. Thompson PP, Kowalski RP. A 13-year retrospective review of

polymerase chain reaction testing for infectious agents from ocular samples. Ophthalmology. 2011;118:1449.

22. Kowalski RP, Thompson PP, Kinchington PR, et al. Evaluation of

the Smart Cycler II system for real-time detection of viruses and

Chlamydia from ocular specimens. Arch Ophthalmol. 2006;

124:1135.

23. Chichili GR, Athmanathan S, Farhatullah S, et al. Multiplex

polymerase chain reaction for the detection of herpes simplex

virus, varicella-zoster virus and cytomegalovirus in ocular specimens. Curr Eye Res. 2003;27:85.

24. Yip PP, Chan WH, Yip KT, et al. The use of polymerase chain

reaction assay versus conventional methods in detecting neonatal

chlamydial conjunctivitis. JPOS. 2008;45:234.

25. Rapoza PA, Quinn TC, Kiessling LA, et al. Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal

antibody stain for Chlamydia. JAMA. 1986;24:3369.


134

Melissa Scala

Chahira Kozma

25 Perimortem Sampling

A. Background

1. Perimortem sampling may help to establish the diagnosis in infants who die before diagnostic evaluation is

completed.

2. Approximately 25% of unexplained infant deaths in the

first week of life are due to undiagnosed congenital

anomalies. Infectious causes may account for a third of

unexplained deaths (1,2).

3. Inborn errors of metabolism are rare individually, but

in the general population the incidence may be >1 in

1,000 live births (3).

4. Diagnostic testing for congenital and metabolic disorders

can be time-consuming, so some infants may go undiagnosed and even die before the exact cause is elucidated.

5. Autopsy is declining worldwide. Neonatal autopsy rates

fell from 80% to 50% by the year 2000 (4).

6. Many parents today question the need for autopsy in an

era of sophisticated diagnostic testing. For some families, cultural or religious traditions may be barriers to

autopsy consent (5).

7. Even with autopsy, perimortem evaluation may be

essential, as some tests have low yield when performed

more than a few hours after death (6).

8. Neonatologists and pediatricians should be prepared to

independently obtain any necessary samples for diagnosis and to counsel the family regarding options for postmortem evaluation.

9. Information gathered during this period can be very

important for current and future generations (7).

10. If time allows, a genetics consult can be very useful in

guiding testing. If an inborn error of metabolism or

genetic disease is suspected, consultation before or

immediately after death is vital.

B. Indications (8,9)

1. Unknown cause of death

2. Suspected genetic disorder

3. Suspected inborn error of metabolism

4. Suspected undiagnosed infection

5. Suspected hypoxic-ischemic encephalopathy (10)

C. Discussion with the Family

1. Families of dying infants are under great strain, particularly if diagnosis is uncertain. An in-depth conversation

with the family can answer any questions they may have

and create a plan for perimortem sampling and for possible autopsy.

2. Informed consent may be obtained at this time for any

planned photographs or procedures.

D. Clinical Information

A detailed history and exam is important, particularly if a

geneticist has been unable to see the infant (3,11).

1. History

a. Maternal history: Ethnicity and medical history

b. Previous pregnancy history: Stillbirths or pregnancy

losses

c. History of this pregnancy, including

(1) Exposure to teratogens

(2) Amniotic fluid volume

(3) Results of amniocentesis and ultrasound

(4) Maternal illness

(5) Fetal movements

d. Family history including three-generation pedigree

(Table 25.1) (11).

e. Infant history: Report medical course for this

infant including diagnoses, treatments, and lab

results

2. Physical exam

a. Should be detailed and performed by specialist in

genetic metabolic disorders if possible

b. Important components include

(1) Growth parameters

(2) Hair pattern

(3) Facial features including eye and ear placement

(4) Abnormalities of hands and feet

(5) Genital and rectal exam

(6) Neurologic findings

(7) Skin abnormalities


Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more